Floatz logo

N-Acetyl-L-Cysteine

Sickle Cell Disease

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 3Dormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
65/ 100

Competitive context

135 Active assets in the Sickle Cell Disease cohort.

Asset / SponsorPhaseRating
Glutamine
Ain Shams University
Phase 4BBB
Hydroxyurea
St. Jude Children's Research Hospital
Phase 4BB
MAGNESIUM METALLICUM
Medical College of Wisconsin
Phase 3BB
FILGRASTIM
St. Jude Children's Research Hospital
Phase 4BB
Crizanlizumab
Novartis Pharmaceuticals
Phase 4BB

View all 50 →

Same molecule, other indications

N-Acetyl-L-Cysteine is also rated in:

idiopathic pulmonary fibrosisDormant
BBB
Indicative ·
74 / 100
View asset →
schizophreniform disorderDormant
BBB
Indicative ·
74 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →